One in three ignore signs of deadly gynae cancers – the red flag symptoms of 5 killers you must check immediately
ALMOST one in three women have put off seeing their GP about worrying gynaecological symptoms that could be signs of cancer, a leading charity has warned.
There are five cancers affecting gynaecological organs, causing symptoms like unusual discharge, bleeding between periods or after the menopause, lumps and pain during sex.
4
The Eve Appeal - a gynae cancer charity - warned that many women may ignore these red flag signs or delay seeing a doctor about them out of embarrassment.
A survey of 1,070 women found that one in three had postponed seeing a GP about possible cancer symptoms.
Nearly one in three respondents also said they would feel nervous, anxious, or uncomfortable speaking to a doctor about gynaecological health issues.
Another 25 per cent revealed they'd feel embarrassed speaking to their GP about such symptoms.
Sixty per cent of the respondents said that seeing a female GP would help them feel more comfortable about getting gynaecological symptoms checked.
Knowing their GP specialised in women's health (46 per cent) and previously having had a positive experience with their GP (40 per cent) would also prompt them to get symptoms checked more quickly, they said.
Another one in four women said they'd feel more comfortable getting symptoms checked if they saw a GP they knew (24 per cent), and if the GP prompted them to open up by asking questions like 'Is there anything else bothering you?' (23 per cent).
Dr Aziza Sesay, GP, said: 'As a GP, these statistics don't surprise me.
"I've seen so many women who come in with one issue, and then once they feel more comfortable, they open up about something else they've been struggling with for a long time, usually in silence - often too embarrassed to mention it at first.
"From symptoms of prolapse and urinary incontinence to bleeding after menopause and vulval swelling.
Cervical cancer could be eradicated as HPV vaccine slashes 90% of cases
"Sadly, in some cases, the delayed presentation has led to a cancer diagnosis at a later stage.
"Destigmatising conversations around these symptoms and breaking the taboo can quite literally save lives.'
Gynaecological cancers - which include womb, ovarian, cervical, vulval and vaginal cancer - affect 22,050 women and people with ovaries each year in the UK.
According to The Eve Appeal, this amounts to 60 people a day receiving a diagnosis, and sadly 22 of them will die from their cancer.
So picking up these cancers early and getting possible signs of them checked as soon as possible can make a real difference
As it launches its annual Get Lippy campaign for May, The Eve Appeal is raising awareness around red flag symptoms of the five diseases.
1. Ovarian cancer
Nearly 7,500 people are diagnosed with ovarian cancer every year in the UK, making it the sixth most common cancer in women.
It's most frequently diagnosed post-menopause, but it can affect anyone with ovaries at any stage of life.
The five main ovarian cancer symptoms are:
Increased abdominal size and persistent bloating (not bloating that comes and goes)
Persistent pelvic and abdominal pain
Unexplained change in bowel habits
Difficulty eating and feeling full quickly, or feeling nauseous
Needing to wee more regularly
Sufferers may also experience back pain, fatigue, weight loss and pain during sex.
2. Womb cancer
Womb cancer may also be referred to as uterine or endometrial cancer.
It's also the fourth most common gynaecological cancer, with over 9,700 people diagnosed every year in the UK.
According to The Eve Appeal, cases have increased by 12 per cent in the last decade.
Abnormal vaginal bleeding is the main symptom of womb cancer, around nine out of 10 sufferers are diagnosed after their abnormal bleeding was investigated.
This irregular bleeding might be:
Vaginal bleeding after the menopause
Bleeding between periods
Bleeding that is unusually heavy
Vaginal discharge that is blood-stained (pink, brown, red)
3. Vulval cancer
Vulval cancer is rare, affecting around 1,350 people a year in the UK - mostly women over the age of 60.
But younger women are also being diagnosed with the cancer, so they should know to look out for:
A lasting itch on the external genitalia (vulva)
Pain or soreness on the external genitalia
Thickened, raised, red, white or dark patches on the skin of the external genitalia
An open sore or growth visible on the genital skin
A mole on the external genitalia that changes shape or colour
A lump or swelling on the external genitalia
4. Vaginal cancer
4
Vaginal cancer is rarer, with 250 people diagnosed with it in the UK each year.
Almost half (40 per cent) of cases are spotted in people over 75.
The most common signs include:
Abnormal bleeding, eg. between periods, after menopause
Discharge with an unpleasant smell or blood stained
Pain during penetrative sex
An internal lump or growth that you or your doctor can feel
An internal itch that won't go away and pain when urinating
Persistent pelvic and internal pain
5. Cervical cancer
Cervical cancer is cancer of the cervix, which connects the womb and vagina - this is also sometimes referred to as the neck of the womb.
It can affect patients at any age, but the incidence is highest in women aged 30 to 34.
Cervical screening programmes and HPV vaccines have reduced rates and save 4,000 lives each year, but there are still around 3,250 new cases in the UK annually, The Eve Appeal warned.
The symptoms of cervical cancer aren't always obvious, and it may not cause any at all until it's reached an advanced stage.
But you might notice:
Unusual bleeding, often after sex
Pain and discomfort during sex
Unpleasant smelling vaginal discharge
Previously offered only to girls, the HPV shot is now available to all 12- and 13-year-olds regardless of gender, and can provide a a vital defence against eight types of cancer - including cervical.
Cervical cancer screening
Nearly all cervical cancers are caused by an infection with certain high-risk types of human papillomavirus (HPV).
HPV is the name for a very common group of viruses that most people will get some type of HPV during their lives.
It's very common and nothing to feel ashamed or embarrassed about.
You can get HPV from any kind of skin-to-skin contact of the genital area, not just from penetrative sex.
This includes:
Vaginal, oral or anal sex
Any skin-to-skin contact of the genital area
Sharing sex toys
In most cases your body will get rid of HPV without it causing any problems.
But sometimes HPV can stay in your body for a long time and some types of high risk types of HPV can cause cervical cancer.
If high risk types of HPV stay in your body, they can cause changes to the cells in your cervix. These changes may become cervical cancer if not treated.
How to lower your risk of cervical cancer
You can't always prevent cervical cancer. But there are things you can do to lower your chances of getting cervical cancer.
Cervical screening and HPV vaccination are the best ways to protect yourself from cervical cancer.
All women and people with a cervix between the ages of 25 and 64 are invited for regular cervical screening. It helps find and treat any changes in the cells of the cervix before they can turn into cancer.
All children aged 12 to 13 are offered the HPV vaccine. It helps protect against the types of HPV that cause most cases of cervical cancer, as well as some other cancers and genital warts.
You can also lower your chance of getting cervical cancer by:
Using condoms, which lower your chance of getting HPV – but they do not cover all the skin around your genitals so you're not fully protected
Quitting smoking – smoking can weaken your immune system and the chemicals in cigarettes can also cause cervical cancer
Source: NHS
Know your normal
Athena Lamnisos, The Eve Appeal CEO, said: 'We know that health prevention and early diagnosis are key when it comes to cancer and that's a two-way street.
"We need patients to feel informed and confident and we need doctors to support open conversations and dispel embarrassment.
"Throughout May, we'll be highlighting this issue and providing tips and information which will stop women thinking 'it's probably nothing' and ignore possible symptoms and get them checked.'
Shalisha James-Davis, who was diagnosed with ovarian cancer, says: 'The fact that I am a young woman played a huge part in my delayed cancer diagnosis.
"I know I still do not look like a cancer patient but that should not be a reason for my symptoms to not be taken seriously.
"I now know what I need to look out for and what is not my normal and I'm hoping to encourage other young women to get to know their own bodies so that they can advocate for themselves.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
a day ago
- Daily Mail
I blamed an embarrassing symptom on menopause... it was actually stage 3 anal cancer
Julia DeVillers never imagined a common sexually transmitted infection she had in college would be the cause of her rare cancer decades later. DeVillers, an author, began experiencing random gushes of blood, seeing red in her underwear. She blamed the bleeding on early signs of menopause - as a woman in her fifties, she figured it was time. One day, she sat poolside and saw blood had soaked the towel beneath her. She said: 'I bled on it, and I thought, 'Wow, this brings me back to my pre-teen years of being traumatized when you get your fist period." I thought, 'This is a very dramatic period.'' Early symptoms of perimenopause, the period preceding menopause, include irregular bleeding of various flows and lengths - but what DeVillers didn't realize was that the bleeding was coming from her anus, not her vagina. She said: 'I didn't know the bleeding was coming from my tush. I thought I was getting my period again.' When she realized, however, she knew bleeding from the anus could be a sign of cancer. Doctors suspected a hemorrhoid to be the culprit, and performed surgery to remove it. But instead of finding swollen veins, doctors found two tumors. She had stage three anal cancer - a rare cancer linked to the STI human papillomavirus (HPV). 'It wasn't non-stop. All of a sudden, I would have a gush of blood. I really begged them to put me on a waiting list [for hemorrhoid removal surgery],' she told TODAY. Her surgery in May 2022 was expected to be a standard, straightforward procedure that would put an end to her suffering. 'When I came out of it, I was really groggy from the anesthesia, but I remember my husband was holding one hand and my doctor was holding the other hand,' DeVillers said. The anal cancer cells had migrated to her lymph nodes, making it stage 3. Between 40 and 70 percent of patients die within five years of being diagnosed with this stage of cancer. Anal cancer, which develops in the anal canal, is rare, with 10,540 new cases in 2024 and 2,190 deaths. It is different from colon or rectal cancer and is typically caused by an HPV infection. In an article DeVillers wrote for Newsweek, she said: 'I'd been married for a million years! But I also remembered back in college my gynecologist saying: "You have human papillomavirus (HPV), don't worry it's common, harmless, and will probably go away by itself."' Estimates suggest 80 percent of sexually active people will contract at least one HPV infection by 45. It is spread via skin-to-skin contact through vaginal, anal or oral sex. It often shows no symptoms. According to the CDC, more than 42million Americans are currently infected with the STI and it is estimated 13million people become infected annually. It is possible to fend off HPV and potentially related cancers with a vaccine for the virus that is 97 percent effective. Doctors prescribed DeVillers with aggressive IV chemotherapy, as well as radiation treatments and oral chemotherapy. Just before three weeks into her treatment and her second chemo infusion, she was doing well, but after her second infusion, she 'seemed to crash and burn,' she told TODAY. Her colon became twisted, causing excruciating pain. She vomited neon green bile and then collapsed in the emergency department. She ended up spending five weeks in the intensive care unit. Doctors noticed her blood cell counts had plummeted, and called her children because they were unsure how much time DeVillers had left. They also enlisted hospice care. 'That was horrible for my family,' she said, adding she could feel her body shutting down. 'I saw this dark tunnel and it had two pricks of white light,' DeVillers said. This lasted 'a day or two and I felt darkness. I was very depressed.' But she began to feel better after a blood transfusion. DeVillers had lost about 30 pounds and became weak and frail, but her cancer had not shrunk enough to get her closer to remission, and she still had to undergo radiation treatment. 'Even as sick as I was, they wheeled me into radiation,' she said. 'My radiologist, I'll forever be grateful for him. He said, 'If we stop now, it could come back. But if we keep going to radiation … that's what's going to get rid of the tumor.'' When her treatment ended in August 2022, doctors approached her with 'cautious good news.' There were no signs of cancer remaining, though they were still worried about a lymph node that had caused a lump in her abdomen. Six months later, though, she was cancer-free. It's been three years since her diagnosis and all of her tests continue to be normal. DeVillers felt embarrassed by her cancer at first. When people asked her about it, she said: ''Yeah, I've got tush cancer.'' 'Anything so I didn't have to say anal and then I learned anal cancer is a different animal from rectal or colon cancer.' Now, she's joined the board of the HPV Cancer Alliance to remove the stigma and raise awareness of HPV-related cancers. She said: 'Women get it. Men get it. It's all directly related to getting HPV.'
Daily Mail
6 days ago
- Daily Mail
Major breakthrough in cancer caused by oral sex - as cases continue to climb in under 50s
Thousands of patients with cancers of the head and neck have been thrown a lifeline by 'world changing' drug that dramatically slows the spread of the disease. The injection, called pembrolizumab, helps the immune system spot hidden cancer cells in the body. It is currently offered to NHS patients with advanced lung, breast and cervical cancers—but expert believe it hold far wider promise. Also known by the brand name Keytruda, a groundbreaking trial found the drug kept head and neck cancers at bay for five years compared to 30 months with standard treatments, including surgery, chemotherapy and radiotherapy. It also slashed the risk of the disease returning elsewhere in the body. Researchers presenting the findings at the American Society of Clinical Oncology conference in Chicago said the injection 'could change the world for these patients' offering them 'years longer than the current standard treatments'. Head and neck cancer is an umbrella term for cancers of the mouth, throat, voice box, nose, sinuses and salivary glands. Until recently, experts believed the main causes were lifestyle-related—particularly smoking and heavy drinking. In recent years, research has suggested that human papillomavirus (HPV) may be responsible for up to 70 per cent of head and neck cancers. HPV is a common virus spread through close contact, including sex, and is usually harmless. However, in some cases—for reasons not fully understood—it can trigger cancerous changes in healthy tissue. The virus is already known to cause cervical, anal and penile cancers. A rise in head and neck cancers, particularly among younger and middle-aged patients, has been linked to oral sex. In the global trial, carried out across 24 countries involving more than 700 head and neck cancer patients, 363 received pembrolizumab followed by standard treatment. The remainder had standard treatment only. Pembrolizumab is a checkpoint inhibitor—it works by helping the immune system recognise and fight cancer. Scientists found the cancer returned in half the patients given pembrolizumab after five years, compared with two-and-a-half years in those receiving standard care. After three years, the risk of cancer returning somewhere else in the body was also 10 per cent lower among those on pembrolizumab. Kevin Harrington, a professor of biological cancer therapies at the Institute of Cancer Research, London, and consultant oncologist at the Royal Marsden NHS Foundation Trust, said: 'For patients with newly-diagnosed, locally-advanced head and neck cancer, treatments haven't changed in over two decades. 'Immunotherapy has been amazingly beneficial for patients with cancer that has come back or spread around the body but, until now, it hasn't been as successful for those presenting for the first time with disease which has spread to nearby areas. 'This research shows that immunotherapy could change the world for these patients—it significantly decreases the chance of cancer spreading around the body, at which point it's incredibly difficult to treat.' Professor Harrington added that the drug 'dramatically increases the duration of disease remission—for years longer than the current standard treatments'. 'It works particularly well for those with high levels of immune markers, but it's really exciting to see that the treatment improves outcomes for all head and neck cancer patients, regardless of these levels,' he said. Laura Marston, 45, from Derbyshire was diagnosed with stage four tongue cancer in 2019 after an ulcer on her tongue didn't heal. She was later referred to The Royal Marsden where she joined the trial. 'I was so excited to be on a clinical trial and knowing I was in the best hands was really reassuring,' she said. 'As part of the trial I underwent two rounds of immunotherapy before undergoing surgery. 'In the months following my surgery I had to relearn how to eat and talk again while also having ten more infusions of immunotherapy, chemotherapy, and radiotherapy. 'My clinical team were amazing and went above and beyond for anything I needed. I am amazed I am still here six years later, this treatment has given me the gift of life.' Cancers that affect the head and neck are the eighth most common form of cancer overall in the UK, although they are two to three times more common in men than in women. About 12,500 new cases are diagnosed each year, according to Cancer Research UK, and incidences are on the rise. Dr Lyndsy Ambler, Cancer Research UK senior strategic evidence manager, said: 'Around 4,100 people die from head and neck cancers every year—that's approximately 11 deaths every day. 'Any potential new treatment options for a disease where there has been limited progress for decades are very welcome. 'Pembrolizumab's potential benefit for people with head and neck cancer could represent a significant step forward in how we treat the disease.'
Daily Mirror
29-05-2025
- Daily Mirror
Emmerdale 'preventable illness' warning for millions of women
A women's health charity is urging people to get tested A women's health charity has issued a reminder to get tested after a heartbreaking soap storyline. Emmerdale has seen teenager Sarah Sugden (played by Katie Hall) given life-changing news following hospital tests. Her diagnosis of cervical cancer spearheads Emmerdale's most recent emotive storyline, which affects around 3,300 women every year in the UK. Cervical cancer is most commonly diagnosed in women between 30-34 years old, however, it can occur at any age, and the storyline highlights the importance of early detection and symptom awareness. In 2023-24, 5.12 million women in England aged between 25-64 were due a Cervical Cancer Screening, however only 3.25 million women were tested. The Lady Garden Foundation, is on a mission to significantly reduce the number of missed appointments through education, open conversation and research alongside The Royal Marsden Hospital. Almost half of women are intentionally putting off important cervical screenings despite 83 per cent also saying they believe they prevent cervical cancer, according to independent research commissioned by the foundation. Research conducted by the charity uncovered that embarrassment was the leading factor as to why cervical screenings were being purposely skipped, with more than one in ten claiming they have put it off due to forgetting to wax or shave beforehand. The NHS cervical screening programme offers testing to women between the ages of 25 and 64. More than five million women are invited for cervical screening each year in England. Approximately 1 in 20 women will have an abnormal screening result meaning high risk HPV is detected in the sample. This does not mean that all women with an abnormal test will develop cervical cancer. Early treatment and increased monitoring can prevent these cervical changes from developing into cancer. Co-founder and Chair of The Lady Garden Foundation Jenny Halpern Prince MBE said: 'The latest storyline in Emmerdale is an authentic portrayal of the journeys many women face each year in the UK and will hopefully spark national conversation, encouraging women to be made aware of the symptoms and the preventative measures to take to protect themselves and their loved ones. "It's vital that mainstream soaps like Emmerdale tackle these real life issues, opening up the dialogue to make people aware of the symptoms and benefits of early detection. 'We set up the Lady Garden Foundation in 2014 to help fund groundbreaking research into the five gynaecological cancers. Over the last 10 years, the foundation has grown as we aim to educate women and girls of all ages to understand the signs of gynae cancers whilst breaking the taboos.' John Butler, Consultant Gynaecological Oncology Surgeon at The Royal Marsden and Medical Director of The Lady Garden Foundation said: 'Cervical cancer is almost entirely preventable due to vaccination in school-age children and regular attendance at the screening programme. It is unlikely that women will develop cervical cancer if they have had their vaccination and regularly attend for cervical screening. If they develop abnormal symptoms such as bleeding after intercourse, bleeding between the periods, pelvic pain, abnormal vaginal discharge or bleeding after menopause, it's important to get checked out as these can indicate there is a problem. "If women are diagnosed with cervical cancer, they will be managed by a group of highly trained professionals who will review the biopsy, arrange appropriate scans and plan the best treatment. The cancer team and specialist nurses are points of contact to help you every step of the way. Please encourage all women to attend for their cervical screening and those between 11 and 25 attend for HPV vaccination. "The good news is that if we can increase vaccination and screening attendance rates cervical cancer could be eradicated in the future.'
